MM

Madhukar Meel

Director Director DIN 06525897
DIN 06525897 First appointment Mar 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Mar 2013
Shareholding value Locked Premium profile

About Madhukar Meel

Data last updated:

Madhukar Meel has 13 years in corporate governance. Formerly with 1 company, such as Axiom Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06525897
Primary Designation Director
First Appointment 12 Mar 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Axiom Pharma Private Limited U24232RJ2009PTC029780
Director12 Mar 20132009Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Axiom Pharma Private Limited
Premium access

Shareholding and investment profile for Madhukar Meel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhukar Meel

Madhukar Meel has 13 years in corporate governance. Formerly with 1 company, such as Axiom Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Madhukar Meel is associated with 0 companies as a director.

Madhukar Meel has expertise in General Business.

Madhukar Meel has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available